company background image
FLRY3 logo

Fleury BOVESPA:FLRY3 주식 보고서

최종 가격

R$13.54

시가총액

R$7.5b

7D

-3.0%

1Y

-20.6%

업데이트

18 Nov, 2024

데이터

회사 재무 +

Fleury S.A.

BOVESPA:FLRY3 주식 보고서

시가총액: R$7.5b

FLRY3 주식 개요

Fleury S.A.는 자회사와 함께 브라질에서 진단, 치료, 임상 분석, 건강 관리, 의료, 정형외과 및 안과 분야의 의료 서비스를 제공하고 있습니다. 자세한 내용

FLRY3 기본 분석
눈송이 점수
가치 평가5/6
미래 성장2/6
과거 실적5/6
재무 상태4/6
배당금4/6

보상

공정 가치 추정치보다 낮은 36.3% 에서 거래

수익은 매년 13.82% 증가할 것으로 예상됩니다.

지난 1년간 수익이 64.3% 증가했습니다.

분석가들은 주가가 41% 상승할 것이라는 데 동의합니다.

위험 분석

불안정한 배당 실적


Fleury S.A. 경쟁사

Oncoclínicas do Brasil Serviços Médicos

BOVESPA:ONCO3

R$2.5b

Odontoprev

BOVESPA:ODPV3

R$5.6b

Rede D'Or São Luiz

BOVESPA:RDOR3

R$66.1b

Profarma Distribuidora de Produtos Farmacêuticos

BOVESPA:PFRM3

R$864.4m

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 Fleury
과거 주가
현재 주가R$13.54
52주 최고치R$18.96
52주 최저치R$13.46
베타0.60
11개월 변경-9.25%
3개월 변경 사항-14.52%
1년 변경 사항-20.63%
33년 변화-24.01%
5년 변화-50.06%
IPO 이후 변화55.80%

최근 뉴스 및 업데이트

We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Nov 15
We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Nov 02
Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

Sep 26
Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

Recent updates

We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Nov 15
We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Nov 02
Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

Sep 26
Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

Jun 18
We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

The Price Is Right For Fleury S.A. (BVMF:FLRY3)

Apr 16
The Price Is Right For Fleury S.A. (BVMF:FLRY3)

Concerns Surrounding Fleury's (BVMF:FLRY3) Performance

Mar 14
Concerns Surrounding Fleury's (BVMF:FLRY3) Performance

Earnings Tell The Story For Fleury S.A. (BVMF:FLRY3)

Jan 05
Earnings Tell The Story For Fleury S.A. (BVMF:FLRY3)

Fleury (BVMF:FLRY3) Has A Pretty Healthy Balance Sheet

Oct 05
Fleury (BVMF:FLRY3) Has A Pretty Healthy Balance Sheet

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Jun 27
Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

Feb 25
We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

At R$18.27, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Sep 26
At R$18.27, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Sep 08
Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Fleury (BVMF:FLRY3) Has Some Way To Go To Become A Multi-Bagger

Jul 01
Fleury (BVMF:FLRY3) Has Some Way To Go To Become A Multi-Bagger

When Should You Buy Fleury S.A. (BVMF:FLRY3)?

Jun 10
When Should You Buy Fleury S.A. (BVMF:FLRY3)?

Is Fleury (BVMF:FLRY3) Using Too Much Debt?

Apr 10
Is Fleury (BVMF:FLRY3) Using Too Much Debt?

Return Trends At Fleury (BVMF:FLRY3) Aren't Appealing

Mar 24
Return Trends At Fleury (BVMF:FLRY3) Aren't Appealing

At R$19.12, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Feb 08
At R$19.12, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Returns On Capital Are Showing Encouraging Signs At Fleury (BVMF:FLRY3)

Dec 08
Returns On Capital Are Showing Encouraging Signs At Fleury (BVMF:FLRY3)

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Nov 05
Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Is Fleury S.A. (BVMF:FLRY3) Potentially Undervalued?

Oct 21
Is Fleury S.A. (BVMF:FLRY3) Potentially Undervalued?

Investors Should Be Encouraged By Fleury's (BVMF:FLRY3) Returns On Capital

Aug 24
Investors Should Be Encouraged By Fleury's (BVMF:FLRY3) Returns On Capital

Fleury (BVMF:FLRY3) Seems To Use Debt Rather Sparingly

Jul 31
Fleury (BVMF:FLRY3) Seems To Use Debt Rather Sparingly

Is It Time To Consider Buying Fleury S.A. (BVMF:FLRY3)?

Jul 07
Is It Time To Consider Buying Fleury S.A. (BVMF:FLRY3)?

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Apr 30
Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Fleury (BVMF:FLRY3) Shareholders Will Want The ROCE Trajectory To Continue

Apr 12
Fleury (BVMF:FLRY3) Shareholders Will Want The ROCE Trajectory To Continue

At R$25.16, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Mar 29
At R$25.16, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Should You Or Shouldn't You: A Dividend Analysis on Fleury S.A. (BVMF:FLRY3)

Mar 16
Should You Or Shouldn't You: A Dividend Analysis on Fleury S.A. (BVMF:FLRY3)

Only One Day Left To Cash In On Fleury's (BVMF:FLRY3) Dividend

Mar 01
Only One Day Left To Cash In On Fleury's (BVMF:FLRY3) Dividend

Fleury S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Feb 28
Fleury S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

What Type Of Shareholders Make Up Fleury S.A.'s (BVMF:FLRY3) Share Registry?

Feb 15
What Type Of Shareholders Make Up Fleury S.A.'s (BVMF:FLRY3) Share Registry?

Shareholders of Fleury (BVMF:FLRY3) Must Be Delighted With Their 360% Total Return

Feb 02
Shareholders of Fleury (BVMF:FLRY3) Must Be Delighted With Their 360% Total Return

Three Days Left To Buy Fleury S.A. (BVMF:FLRY3) Before The Ex-Dividend Date

Jan 03
Three Days Left To Buy Fleury S.A. (BVMF:FLRY3) Before The Ex-Dividend Date

Should We Be Excited About The Trends Of Returns At Fleury (BVMF:FLRY3)?

Dec 28
Should We Be Excited About The Trends Of Returns At Fleury (BVMF:FLRY3)?

Would Fleury S.A. (BVMF:FLRY3) Be Valuable To Income Investors?

Dec 12
Would Fleury S.A. (BVMF:FLRY3) Be Valuable To Income Investors?

Taking A Look At Fleury S.A.'s (BVMF:FLRY3) ROE

Nov 29
Taking A Look At Fleury S.A.'s (BVMF:FLRY3) ROE

Getting In Cheap On Fleury S.A. (BVMF:FLRY3) Might Be Difficult

Aug 30
Getting In Cheap On Fleury S.A. (BVMF:FLRY3) Might Be Difficult

Here's What You Should Know About Fleury S.A.'s (BVMF:FLRY3) 3.8% Dividend Yield

Aug 18
Here's What You Should Know About Fleury S.A.'s (BVMF:FLRY3) 3.8% Dividend Yield

Can Fleury S.A. (BVMF:FLRY3) Improve Its Returns?

Aug 03
Can Fleury S.A. (BVMF:FLRY3) Improve Its Returns?

주주 수익률

FLRY3BR HealthcareBR 마켓
7D-3.0%0.3%-0.06%
1Y-20.6%-13.6%-1.6%

수익률 대 산업: FLRY3 지난 1년 동안 -13.6 %를 반환한 BR Healthcare 업계보다 저조한 성과를 냈습니다.

수익률 대 시장: FLRY3 지난 1년 동안 -1.6 %를 반환한 BR 시장보다 저조한 성과를 냈습니다.

가격 변동성

Is FLRY3's price volatile compared to industry and market?
FLRY3 volatility
FLRY3 Average Weekly Movement3.1%
Healthcare Industry Average Movement6.1%
Market Average Movement4.5%
10% most volatile stocks in BR Market8.5%
10% least volatile stocks in BR Market2.3%

안정적인 주가: FLRY3 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.

시간에 따른 변동성: FLRY3 의 주간 변동성( 3% )은 지난 1년 동안 안정적인 모습을 보였습니다.

회사 소개

설립직원CEO웹사이트
192627,000Jeane Tsutsuiri.fleury.com.br

Fleury S.A.는 자회사와 함께 브라질에서 진단, 치료, 임상 분석, 건강 관리, 의료, 정형외과 및 안과 분야의 의료 서비스를 제공하고 있습니다. 이 회사는 세 가지 부문을 통해 운영됩니다: 진단 의학, 통합 의학, 치과입니다. 실험실 및 영상 검사, 유전체학, 건강 관리 및 플랫폼, 진단 정보, 검진 및 참조 실험실, 클리닉 데이, 인퓨전 센터, 정형외과 및 안과, 치과 영상 검사, 진단 영상 서비스 등을 제공합니다.

Fleury S.A. 기본 사항 요약

Fleury 의 수익과 매출은 시가총액과 어떻게 비교하나요?
FLRY3 기본 통계
시가총액R$7.49b
수익(TTM)R$613.53m
수익(TTM)R$7.55b

12.0x

P/E 비율

1.0x

P/S 비율

FLRY3 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
FLRY3 손익 계산서(TTM)
수익R$7.55b
수익 비용R$5.46b
총 이익R$2.09b
기타 비용R$1.48b
수익R$613.53m

최근 보고된 수익

Sep 30, 2024

다음 수익 날짜

n/a

주당 순이익(EPS)1.13
총 마진27.69%
순이익 마진8.13%
부채/자본 비율71.2%

FLRY3 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기

배당금

4.3%

현재 배당 수익률

13%

지급 비율